Excerpts

IL-6 showed the most pronounced significance (p < 0.001), followed by PT-INR (p = 0.028), and HDL, which demonstrated a borderline significant difference (p = 0.050).

In eight of the 11 questions, a statistically significant difference was recorded at p<0.001 (questions 1, 3, 5, 7, 8, 9, and 11), and in the two marginally statistically significant differences, p = 0.05 (questions 4 and 10) were established.

This increase was statistically insignificant in the dexmedetomidine group (p = 0.069), and highly significant in the remifentanil group (p < 0.05).

A network metanalysis of five phase-III RCTs of triple combination therapy reported comparable improvement of ACQ scores in which both MD and HD ICS/LABA/LAMA FDCs and HD ICS/LABA FDC+TIO were equally (p > 0.05) effective in improving ACQ score, although a trend toward significance (p = 0.05) was detected for HD ICS/LABA/LAMA versus MD ICS/LABA/LAMA FDC [ 24 ].

Specifically, GLS exhibited a decrease during chemotherapy compared to the baseline, demonstrating borderline significance 18.5±2.3 versus -19.6±1.6 (p=0.05).

The rates of myocardial infarction (MI) approached significance (P = 0.05), and the mortality rates were comparable over a two-year period after CABG (4.7%) and at shorter intervals.

The decrease from baseline observed from time point T30 onwards was highly significant (p < 0.05).

1%; p = 0.001), and end-stage liver disease showed a marginally significant difference (7.5% vs. 2%; p = 0.050).

MD: -0.10 (95% CI: -0.21 to 0.00), with a slightly significant (p=0.05) difference and low heterogeneity (I 2 =0%), as illustrated in Figure 3 .

The meta-analysis revealed a borderline significant 24% relative risk reduction in stroke incidence (risk ratio 0.76, 95% confidence interval 0.57-1.00, p = 0.05).

pylori infection (14.4%) was highly significant (p < 0.05) (Table 3 ).

Operative time differed significantly across groups (p = 0.022), while estimated blood loss showed borderline significance (p = 0.050).

Male sex showed a trend toward reduced failure risk (OR 0.38, p=0.050), narrowly missing statistical significance, suggesting possible sex-related biological or anatomical influences on access durability.

A highly significant difference was found between difficulty level and the use of CMB (P < 0.05) and SMB (P = 0.000) (Table 2 ).

Variables used in the multivariate model were those that had shown a marginally significant (p < 0.05) relation with the perinatal outcomes in univariate analysis.

PRP at 12 weeks showed a trend toward optimal results (SMD = 0.66, 95% CI: -0.38 to 1.69, p = 0.21), and the improvement at 6 months was marginally significant (SMD = 0.35, 95% CI: 0.00 to 0.70, p = 0.05).

Gender also displayed a marginally significant association with knowledge levels (p < 0.05), with female participants achieving a higher knowledge score (73.5%) than males (26.5%).

This trend was reflected in our meta-analysis, which showed a borderline significant reduction in the odds of requiring mechanical ventilation in vitamin D-sufficient patients (p=0.05), further reinforcing the potential respiratory benefits of adequate vitamin D levels in this population.

Analysis of All Cerebral Hemispheres The bilateral presence of CMA showed a trend (chi-squared = 3.79; p = 0.05) toward being more common in males (167/192, 86.98%) than in females (210/264, 79.55%).

The education level exhibits borderline significance (p=0.05), suggesting a potential weak correlation, as people possessing a diploma or secondary education demonstrate marginally elevated mean values relative to those with higher educational attainment.

Other measures, such as cardiac anxiety, physical functioning, and overall health, approached significance but did not meet the threshold (p > 0.05).

The logistic regression analysis results show that age >55 years, urinary tract infection (UTI), diabetes, CKD, stone burden, percutaneous access number >1, and Amplatz sheath size >30Fr are highly significant predictors of complications (p <0.05).

Similarly, the test for causes of injury yielded a chi-square statistic of 21.43 with a p-value of 0.00002, suggesting a highly significant difference in the distribution of injury causes (p < 0.05).

41.5%) and reached borderline significance (p=0.05).

Lower Vitamin D levels showed a borderline significant association with abnormal HRUS (p=0.050) and were strongly associated with higher SPADI-Disability scores (p=0.001).